BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Agenus (Formerly known as Antigenics Inc. - Lexington, MA) 

3 Forbes Road

Lexington  Massachusetts  02421  U.S.A.
Phone: 781-721-3500 Fax: 781-938-6496


SEARCH JOBS




Industry
Biotechnology






 Company News
Agenus (AGEN) To Report Second Quarter 2014 Financial Results On July 24, 2014; Conference Call To Follow 7/17/2014 8:03:37 AM
Agenus (AGEN)'s Brain Cancer Vaccine Doubles Survival Rate In Phase 2 Study 7/1/2014 1:46:28 PM
Agenus (AGEN) Brain Cancer Vaccine Shows Extended Survival In Phase 2 Final Data Analysis 7/1/2014 11:01:49 AM
Agenus (AGEN) Vaccine Shows Significant Reduction In Viral Burden After HerpV Generated Immune Activation 6/26/2014 10:46:41 AM
Massachusetts' Agenus (AGEN) Touts Positive Phase 2 Data From HerpV Study 6/26/2014 6:02:11 AM
Agenus (AGEN) Selected For Inclusion In The Russell 3000 Index And Global Index 6/16/2014 11:53:46 AM
Agenus (AGEN) To Present At Jefferies and Co. 2014 Global Healthcare Conference 5/30/2014 7:25:27 AM
Agenus (AGEN) Reports First Quarter 2014 Financial Results 5/8/2014 9:08:23 AM
Agenus (AGEN) To Report First Quarter 2014 Financial Results On May 8, 2014; Conference Call To Follow 4/29/2014 10:23:18 AM
Agenus (AGEN) Could Net $100 Million From Cancer Immunotherapy Pact With Merck & Co., Inc. (MRK) 4/28/2014 6:50:14 AM
12345678910...